Detailed TOC of TransMedics, Inc. - Product Pipeline Analysis, 2016 Update
Table of ContentsTable of Contents 2
List of Tables 4
List of Figures 5
TransMedics, Inc. Company Snapshot 6
TransMedics, Inc. Company Overview 6
TransMedics, Inc. Pipeline Products and Clinical Trials Overview 7
TransMedics, Inc. – Pipeline Analysis Overview 9
Key Facts 9
TransMedics, Inc. - Major Products and Services 10
TransMedics, Inc. Pipeline Products by Development Stage 11
TransMedics, Inc. Clinical Trials by Trial Status 13
TransMedics, Inc. Pipeline Products Overview 15
OCS Heart Device 15
OCS Heart Device Product Overview 15
OCS Heart Device Clinical Trial 16
OCS Kidney Device 17
OCS Kidney Device Product Overview 17
OCS Liver Device 18
OCS Liver Device Product Overview 18
OCS Liver Device Clinical Trial 19
OCS Lung Device 20
OCS Lung Device Product Overview 20
OCS Lung Device Clinical Trial 21
TransMedics, Inc. - Key Competitors 22
TransMedics, Inc. - Key Employees 23
TransMedics, Inc. - Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
TransMedics, Inc., Recent Developments 25
Mar 29, 2016: University of Michigan Health System tests beating heart transplants 25
Feb 23, 2016: TransMedics Announces The World's First Human Liver Transplantation Using The Organ Care System (OCS) Liver Technology & The Initiation of The OCS Liver PROTECT U.S. Pivotal Trial 25
Nov 02, 2015: FDA Postpones TransMedics Advisory Panel Meeting 26
Oct 01, 2015: FDA Panel To Discuss On TransMedics PMA Application For OCS Heart Device 27
Apr 15, 2015: The Lancet Publishes The First Ever Successful Series of Clinical Heart Transplants From DCD Donors Using The TransMedics Organ Care System 27
Apr 15, 2015: The Results of The International PROCEED II Heart Trial with the Organ Care System Were Published in The Prestigious Lancet Journal 28
Mar 26, 2015: TransMedics Organ Care System Used at Papworth Hospital to Perform First Ever European Transplant of a Heart that had stopped Beating in The Donor's Body 28
Oct 24, 2014: The TransMedics Organ Care System (OCS) Heart Technology Was Used to Perform The World's First Series of Adult Human Heart Transplants From Donors After Circulatory Death (DCD Donors) at St Vincent's Hospital in Sydney, Australia 29
Apr 14, 2014: TransMedics Announced Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT 30
Nov 08, 2013: TransMedics Appointed Jeffrey E. Young as Chief Financial Officer 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Figures, Tables and Charts Available in TransMedics, Inc. - Product Pipeline Analysis, 2016 Update
List of TablesTransMedics, Inc. Pipeline Products and Clinical Trials Overview 7
TransMedics, Inc. Pipeline Products by Equipment Type 7
TransMedics, Inc. Pipeline Products by Indication 8
TransMedics, Inc. Clinical Trials by Trial Status 8
TransMedics, Inc., Key Facts 9
TransMedics, Inc., Major Products and Services 10
TransMedics, Inc. Number of Pipeline Products by Development Stage 11
TransMedics, Inc. Pipeline Products Summary by Development Stage 12
TransMedics, Inc. Clinical Trials by Trial Status 13
TransMedics, Inc. Clinical Trials Summary 14
OCS Heart Device - Product Status 15
OCS Heart Device - Product Description 15
OCS Heart Device - International Trial to Evaluate the Safety and Effectiveness of The Portable Organ Care System (OCS) Heart for Preserving and Assessing Expanded Criteria Donor Hearts for Transplantation (EXPAND Heart Trial) 16
OCS Kidney Device - Product Status 17
OCS Kidney Device - Product Description 17
OCS Liver Device - Product Status 18
OCS Liver Device - Product Description 18
OCS Liver Device - International Randomized Trial to Evaluate the Effectiveness of the Portable Organ Care System (OCS) Liver for Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial) 19
OCS Liver Device - Single-arm Prospective Trial to Evaluate the Safety and Performance of the Portable Organ Care System (OCS) Liver for Preserving and Assessing Donor Livers for Transplantation 19
OCS Lung Device - Product Status 20
OCS Lung Device - Product Description 20
OCS Lung Device - International Trial to Evaluate the Safety and Effectiveness of the Portable Organ Care System (OCS) Lung for Recruiting, Preserving and Assessing Expanded Criteria Donor Lungs for Transplantation (EXPAND Trial) 21
TransMedics, Inc., Key Employees 23
List of Figures
TransMedics, Inc. Pipeline Products by Equipment Type 8
TransMedics, Inc. Pipeline Products by Development Stage 11
TransMedics, Inc. Clinical Trials by Trial Status 13
Keyplayers in TransMedics, Inc. - Product Pipeline Analysis, 2016 Update
Tissue Genesis, Inc.Philips Healthcare
Novobion Oy
InfraReDx, Inc.